<p>China Resources Pharmaceutical Group Ltd. announced that its non-wholly-owned subsidiary, Dong-E-E-Jiao Company Limited, will invest approximately RMB 1.421 billion in the construction of a Health Consumer Products Industrial Park. The project will include manufacturing, warehousing, and logistics facilities and will be funded by Dong-E-E-Jiao’s internal resources. This investment aims to expand the company’s health consumer products business and support the implementation of Dong-E-E-Jiao’s strategic growth model. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260210-12020709), on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

000423

China Resources Pharmaceutical Invests in Health Consumer Products Industrial Park